NILO, ANNACARMEN
 Distribuzione geografica
Continente #
NA - Nord America 1.320
AS - Asia 1.229
EU - Europa 616
SA - Sud America 243
AF - Africa 32
OC - Oceania 3
Totale 3.443
Nazione #
US - Stati Uniti d'America 1.282
SG - Singapore 658
IT - Italia 228
BR - Brasile 189
CN - Cina 176
HK - Hong Kong 136
VN - Vietnam 109
DE - Germania 92
RU - Federazione Russa 84
FI - Finlandia 36
GB - Regno Unito 36
IN - India 35
AR - Argentina 28
FR - Francia 25
KR - Corea 24
IE - Irlanda 19
NL - Olanda 18
BD - Bangladesh 16
UA - Ucraina 16
AT - Austria 15
CA - Canada 15
MX - Messico 14
JP - Giappone 11
TG - Togo 11
ZA - Sudafrica 11
TR - Turchia 10
LT - Lituania 9
EC - Ecuador 8
PL - Polonia 8
ES - Italia 7
IL - Israele 7
SE - Svezia 7
BE - Belgio 6
IQ - Iraq 6
PY - Paraguay 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
MA - Marocco 4
NP - Nepal 4
PE - Perù 4
SA - Arabia Saudita 4
AU - Australia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
IR - Iran 3
JO - Giordania 3
AM - Armenia 2
AZ - Azerbaigian 2
BY - Bielorussia 2
CL - Cile 2
DZ - Algeria 2
HN - Honduras 2
ID - Indonesia 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
PK - Pakistan 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EG - Egitto 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KH - Cambogia 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
SR - Suriname 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
Totale 3.443
Città #
Singapore 310
Ashburn 178
Hong Kong 136
Chandler 121
Beijing 81
Fairfield 66
Los Angeles 53
Boardman 51
Munich 49
Woodbridge 45
Seattle 44
Ho Chi Minh City 37
Venezia 36
Dallas 31
New York 29
Udine 29
Wilmington 29
Hefei 24
Seoul 24
Houston 22
Santa Clara 22
Cambridge 20
Ann Arbor 19
Dublin 19
Helsinki 19
Princeton 19
Tavagnacco 19
Milan 18
Redondo Beach 18
São Paulo 18
Buffalo 17
Ogden 17
Buenos Aires 16
Hanoi 15
Dong Ket 14
Rome 14
Redmond 13
Codroipo 11
Hyderabad 11
Lappeenranta 11
Lomé 11
Nuremberg 11
Boston 10
Dearborn 10
Mexico City 10
Amsterdam 9
Düsseldorf 9
Jacksonville 9
London 9
Tokyo 9
Da Nang 8
Frankfurt am Main 8
Montreal 8
Phoenix 8
Haiphong 7
Manchester 7
Norwalk 7
Stockholm 7
Trieste 7
Vienna 7
Warsaw 7
Brussels 6
Guangzhou 6
Johannesburg 6
Lauterbourg 6
Rio de Janeiro 6
San Francisco 6
Turku 6
Belo Horizonte 5
Bologna 5
Chennai 5
Chicago 5
Dhaka 5
Izmir 5
Orem 5
Poplar 5
Villongo 5
Atlanta 4
Belluno 4
Curitiba 4
Grand Forks 4
Guarulhos 4
New Delhi 4
Portsmouth 4
Salvador 4
San Diego 4
Suzhou 4
Tashkent 4
The Dalles 4
Asunción 3
Baghdad 3
Bari 3
Brooklyn 3
Denver 3
Glen Rock 3
Halle 3
Jequié 3
Lima 3
Mumbai 3
Newark 3
Totale 2.071
Nome #
ADMA as a possible marker of endothelial damage. A study in young asymptomatic patients with cerebral small vessel disease. 192
Timing use of novel anti-epileptic drugs: is earlier better? 137
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features 127
Risk Assessment by Pre-surgical Tractography in Left Hemisphere Low-Grade Gliomas 121
Pharmacokinetic and pharmacodynamic considerations for the clinical efficacy of perampanel in focal onset seizures 118
Investigational therapies for the treatment of narcolepsy 111
Is the Asymmetric Dimethylarginine (ADMA) the Possible Molecule Driving Endothelial Damage in Young Asymptomatic Patients with Cerebral Small Vessel Disease? 106
Epilepsy with eyelid myoclonias (Jeavons syndrome): an electro-clinical study of 40 patients from childhood to adulthood 98
Clinical and magnetic resonance study of a case of subacute sclerosing panencephalitis treated with ketogenic diet 95
Benign EEG variants in the sleep–wake cycle: A prospective observational study using the 10–20 system and additional electrodes 94
Epilepsy and episodic ataxia type 2: family study and review of the literature 93
Can epilepsy affect normal EEG variants? A comparative study between subjects with and without epilepsy 86
Current and emerging pharmaceutical strategies for the treatment and management of restless legs syndrome 83
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome 82
Reply letter to "COVID-19 and Recurrent Status Epilepticus" 78
Efficacy of Perampanel in Refractory and Super-Refractory Status Epilepticus with Suspected Inflammatory Etiology: A Case Series 77
Predictive factors of Status Epilepticus and its recurrence in patients with adult–onset seizures: A multicenter, long follow–up cohort study 76
Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model 72
Early Introduction of Cenobamate in Uncontrolled Focal Epilepsy: Insights from a Structured Controversy 71
Seizures, Epilepsy, and NORSE Secondary to Autoimmune Encephalitis: A Practical Guide for Clinicians 70
Post-Stroke Status Epilepticus: Time of Occurrence May Be the Difference? 70
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome 69
What’s behind drawing for an artist with left temporal lobe epilepsy? A multimodal neurophysiological study 69
Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up 67
Adjunctive Perampanel in Older Patients With Epilepsy: A Multicenter Study of Clinical Practice 66
Meningioma-Related Epilepsy: A Happy Ending? 66
Effect of Dexmedetomidine versus Propofol on Intraoperative Seizure Onset During Awake Craniotomy: A Retrospective Study 66
Performing real time neuropsychological testing during awake craniotomy: are dexmedetomidine or propofol the same? A preliminary report 64
Intravenous brivaracetam in status epilepticus: A multicentric retrospective study in Italy 64
Neurological disorders in COVID-19: a case of Acute Disseminated Encephalomyelitis in an adult patient 63
Turning off the siren of the night: botulinum toxin for the treatment of nocturnal groaning. A case series 63
Erenumab Impact on Sleep Assessed With Questionnaires and Home-Polysomnography in Patients With Migraine: The ERESON Study 59
Prognostic factors in epilepsy with eyelid myoclonia (Jeavons syndrome) 59
An “epileptic scent”: Olfactory auras in tumor-related epilepsy 58
Ketogenic Diet Improves Sleep Quality and Daytime Sleepiness in Chronic Migraine: A Pilot Study 57
Ischemic strokes in COVID-19: risk factors, obesity paradox, and distinction between trigger and causal association 57
Recurrent Status Epilepticus and SARS-CoV-2 infection: the "perfect storm" 57
Spikes/spike-waves time-locked to the flash frequency during intermittent light stimulation in Jeavons syndrome 57
New-onset status epilepticus in SARS-CoV-2 infection: a case series 57
Aging in multiple sclerosis: from childhood to old age, etiopathogenesis, and unmet needs: a narrative review 55
A real‐world comparison among third‐generation antiseizure medications: Results from the COMPARE study 54
A retrospective multicentric study on the effectiveness of intravenous brivaracetam in seizure clusters: Data from the Italian experience 52
Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition 52
Reader Response: Prolonged Unconsciousness Following Severe COVID-19 52
Brivaracetam as add‐on treatment in focal epilepsy: A real‐world time‐based analysis 49
Association of the Timing and Type of Acute Symptomatic Seizures With Poststroke Epilepsy and Mortality 47
Late epileptic seizures following cerebral venous thrombosis: a systematic review and meta-analysis 34
Implications for driving based on the risk of seizures after ischaemic stroke 31
Intraoperative Seizures in Glioma Surgery: Is It Really Only an Intraoperative Issue? 27
Pre- and Post-surgical Poor Seizure Control as Hallmark of Malignant Progression in Patients With Glioma? 22
Perampanel effects on seizures and sleep quality in people with epilepsy: A prospective multicenter study 7
Totale 3.657
Categoria #
all - tutte 18.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021171 0 0 0 0 0 15 16 11 77 12 9 31
2021/2022190 8 8 55 8 1 2 7 7 1 20 54 19
2022/2023280 20 35 0 32 19 80 4 23 23 7 17 20
2023/2024253 20 16 12 8 14 8 2 38 30 52 8 45
2024/20251.161 43 62 126 39 60 33 98 68 169 85 154 224
2025/20261.331 217 319 153 216 318 108 0 0 0 0 0 0
Totale 3.657